What's New in Obesity Treatment?
US$ 23.69
glp-1 market size 2023 Receptor Agonist GLP-1 Agonists Weight Loss Drugs
Description
Role of dapagliflozin and liraglutide on diabetes-induced cardiomyopathy in rats: implication of oxidative stress, inflammation, and apoptosis
Efficacy and safety of the new appetite suppressant, liraglutide: A meta-analysis of randomized controlled trials
Importantly, many of these effects are not a downstream effect of losing weight
That could position the drugs to tackle one of the worlds leading causes of death
Doctors have coined the term "Ozempic face" to describe the hollowed cheeks, sagging skin, and aged appearance that can result from significant weight loss induced by the drug
